General Information of This Antibody
Antibody ID
ANI0ZRONB
Antibody Name
Anti-gp41 mAb 7B2
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
Envelope glycoprotein gp160 (env)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
Anti-gp41 mAb ricin A chain [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
0.20 ng/mL -125 ng/mL
Method Description
Target cells (1000-2000) were plated in triplicate in 96-well flat bottom tissue culture plates in 100 uL tissue culture medium in the presence of the indicated concentration of mAb for 1 h at 37. The secondary immunotoxin, goat anti-human IgG conjugated to ricin A chain, was then added at a final concentration of 300 ng/mL in 100 uL, and the cells were incubated for 3 days.

   Click to Show/Hide
In Vitro Model Human immunodeficiency virus type 1 HEK293/92UG cells .
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
8 ng/mL - 15 ng/mL
Method Description
Target cells (1000-2000) were plated in triplicate in 96-well flat bottom tissue culture plates in 100 uL tissue culture medium in the presence of the indicated concentration of mAb for 1 h at 37. The secondary immunotoxin, goat anti-human IgG conjugated to ricin A chain, was then added at a final concentration of 300 ng/mL in 100 uL, and the cells were incubated for 3 days.

   Click to Show/Hide
In Vitro Model Human immunodeficiency virus type 1 H9/NL4-3 cells .
References
Ref 1 Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1. Vaccines (Basel). 2023 Apr 12;11(4):829. doi: 10.3390/vaccines11040829.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.